Skip to main content
Log in

Adverse reactions to tick-borne encephalitis vaccine: FSME-Immun®

  • Clinical and Epidemiological Studies
  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Vaccination against tick-borne encephalitis with FSME-Immun® vaccine was started in the Department of Infectious Diseases, University Medical School of Białystok, Poland, in 1992. No serious adverse reactions after vaccine administration were observed. Post-vaccine side effects were reported in 242 (11.3%) persons after the first dose (n=2,135) and only in 14 patients (1.2%) after the second one (n=1,183). These effects were mild and transitory. No relationship was observed between the frequency of adverse reactions, general or local, and the initial anti-TBE virus antibody titres or the age of the immunized individuals. Post-vaccine side effects were reported significantly more frequently among people not bitten by ticks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Przesmycki, F., Taytsch, Z., Wróblewska, Z.: Investigation of natural focus of encephalitis in the “Puszcza Białowieska” National Park. J. Infect. Dis. 106 (1960) 276–283.

    CAS  PubMed  Google Scholar 

  2. Jezyna, Cz., Zajac, W., Ciesielski, T., Pancewicz, S.: Epidemiologische und klinische Untersuchungen von Kranken mit Zecken-Encephalitis aus Nord-Ost Polen. Zbl. Bakt. Hyg. I Abt. Orig. B 178 (1984) 510–521.

    CAS  Google Scholar 

  3. Prokopowicz, D., Bobrowska, E., Bobrowski, M., Grzeszczuk, A.: Prevalence of antibodies against tick-borne encephalitis among residents of north-eastern Poland. Scand. J. Infect. Dis. 27 (1995) 15–16.

    Article  CAS  PubMed  Google Scholar 

  4. Kunz, C., Heinz, F. W., Hofmann, H.: Immunogenicity and reactogenicity of highly purified vaccine against tick-borne encephalitis. J. Med. Virol. 6 (1980) 103–106.

    Article  CAS  PubMed  Google Scholar 

  5. Kunz, C., Hofmann, H., Dippe, H.: Die FSME-Impfung, eine Maßnahme der Vorsorgemedizin mit hoher Akzeptanz in Österreich. Wien. med. Wochenschr. 12 (1991) 273–276.

    Google Scholar 

  6. Żabicka, J.: Tick-borne encephalitis in Poland (in Polish). Przegl. Epidemiol. 48 (1994) 197–203.

    PubMed  Google Scholar 

  7. Holzmann, H., Vorobyova, M. S., Ladyzhenskaya, I. P., Ferenczi, E., Kundi, M., Kunz, C., Heinz, F. X.: Molecular epidemiology of tickborne encephalitis virus: cross-protection between European and Far Eastern subtypes. Vaccine 10 (1992) 345–349.

    Article  CAS  PubMed  Google Scholar 

  8. Chen, R. T., Rastogi, S. C., Mullen, J. R., Hayes, S. W., Cochi, S. L., Donlon, J. A., Wassilak, S. G.: The vaccine adverse event reporting system (VAERS). Vaccine 12 (1994) 542–550.

    Article  CAS  PubMed  Google Scholar 

  9. Kunz, C.: Aktive und passive Immunoprophylaxe der Frühsommer-Meningoenzephalitis (FSME). Arzneimittelforschung 28 (1978) 1806.

    Google Scholar 

  10. Molnár, E., Erdös, L., Foronosi, F.: Field trials with TBE-vaccine “FSME-IMMUN” in Hungary. International Symposium Baden/Vienna, October 1979. In:Kunz, C. (ed.): Tick-borne encephalitis. Facultas-Verlag, Wien 1981, pp. 180–192.

    Google Scholar 

  11. Vlasimská, H., Smejkalová, H.: Reactions after vaccination against tick-borne encephalitis. Epidemiol. Microbiol. Immunol. 441 (1995) 26–28.

    Google Scholar 

  12. Girgsdies, O. E., Rosenkranz, G.: Tick-borne encephalitis: development of a pediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine 15 (1996) 1421–1428.

    Google Scholar 

  13. Bohus, M., Glocker, F. X., Jost, S., Deuschl, G., Lücking, C. H.: Myelitis after immunization against tick-borne encephalitis (letter). Lancet 324 (1993) 239–240.

    Article  Google Scholar 

  14. Goerre, S., Kesselring, J., Hartman, K., Kuln, M., Reinhart, W. H.: Neurologische Nebenwirkungen nach Impfung gegen Frühsommer-Meningoenzephalitis. Schweiz. Med. Wochenschr. 123 (1993) 654–657.

    CAS  PubMed  Google Scholar 

  15. Jellinger, K.: Frühsominer-Meningoenzephalitis-Impfung (letter). Dtsch. med. Wochenschr. 117 (1992) 1298–1299.

    CAS  PubMed  Google Scholar 

  16. Sander, D., Scholz, C. W., Eiben, P., Klingelhöfer, J.: Postvaccinal plexus neuropathy following vaccination against tick-borne encephalitis and tetanus in a competitive athlete. Clin. Invest. 72 (1994) 399.

    Article  CAS  Google Scholar 

  17. Gold, R., Wiethölter, H., Rihs, I., Löwer, J., Kappos, L.: Frühsommer-Meningoenzephalitis-Impfung. Indikation und kritische Beurteilung neurologischer Impfkomplikationen. Dtsch. med. Wochenschr. 117 (1992) 112–116.

    CAS  PubMed  Google Scholar 

  18. Scholz, E., Wiethölter, H.: Postvakzinale Schwerpunktneuritis nach prophylaktischer FSME-Impfung. Dtsch. med. Wochenschr. 112 (1987) 544–546.

    Article  CAS  PubMed  Google Scholar 

  19. Schabet, M., Wiethölter, H., Grodd, W., Vallbracht, A., Dichgans, J., Becker, W., Berg, P. A.: Neurological complications after simultaneous immunization against tick-borne encephalitis and tetanus. Lancet i (1989) 959–960.

    Article  Google Scholar 

  20. Wolf, P.: FSME-Impfung und zerebrale Krampfanfälle. Dtsch. med. Wochenschr. 116 (1991) 434.

    CAS  PubMed  Google Scholar 

  21. Rosenkranz, G.: Can we reduce a dose of a vaccine? Controlled Clin. Trials 18 (1997) 43–53.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grzeszczuk, A., Sokolewicz-Bobrowska, E. & Prokopowicz, D. Adverse reactions to tick-borne encephalitis vaccine: FSME-Immun®. Infection 26, 385–388 (1998). https://doi.org/10.1007/BF02770841

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02770841

Keywords

Navigation